LON:ETX

e-therapeutics (ETX) Share Price, News & Analysis

e-therapeutics logo

About e-therapeutics Stock (LON:ETX)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2.52 million shs
Average Volume
758,869 shs
Market Capitalization
£52.59 million
P/E Ratio
N/A
Dividend Yield
3.35%
Price Target
N/A
Consensus Rating
N/A

Company Overview

e-therapeutics plc engages in drug discovery research activities in the United Kingdom. It offers HepNet, a proprietary, hepatocyte-specific, and computational biology platform that addresses key limitations of the biopharmaceutical industry, including extracting value from big data, addressing complex diseases, and improving translatability in research and development; and GalOmic, a RNA interference (RNAi) chemistry platform, which enables the generation of GalNAc-conjugated short interfering RNA drug candidates for hepatocyte-specific gene silencing through RNAi of any target gene identified by HepNet. The company was incorporated in 2001 and is based in London, the United Kingdom.

Receive ETX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for e-therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ETX Stock News Headlines

e-therapeutics Relaunches as Tangram Therapeutics and Unveils LLibra OS
CFA: Bank of America Said THIS
On January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savings account… The digital dollar is inevitable. Think about what this means... When the digital dollar goes live, every dollar you saved could suddenly be trackable at the transaction level. Imagine the worst case scenario: You’re now subject to new digital withdrawal limits and spending restrictions. Your account can be frozen remotely without court approval. But here's what Bank of America didn't say: There's still a way to protect your wealth before this digital prison locks. While everyone else gets trapped in the digital system, my research team has been positioning members outside that reach… completely under their own control. No government tracking. No withdrawal limits. No remote freezing.tc pixel
See More Headlines

ETX Stock Analysis - Frequently Asked Questions

e-therapeutics plc (LON:ETX) announced its earnings results on Tuesday, March, 17th. The company reported GBX (0.87) earnings per share for the quarter, beating analysts' consensus estimates of GBX (0.90) by GBX 0.03.

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
LON:ETX
CIK
N/A
Fax
N/A
Employees
35
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£10.06 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-38.75%
Return on Assets
-29.10%

Debt

Debt-to-Equity Ratio
0.33
Current Ratio
22.20
Quick Ratio
20.13

Sales & Book Value

Annual Sales
£295 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
5.07
Book Value
GBX 5 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
584,330,000
Free Float
N/A
Market Cap
£52.59 million
Optionable
Not Optionable
Beta
0.46
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (LON:ETX) was last updated on 5/8/2024 by MarketBeat.com Staff.
From Our Partners